These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 24661212)
1. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area. Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212 [TBL] [Abstract][Full Text] [Related]
2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models. Chung TD Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951 [TBL] [Abstract][Full Text] [Related]
3. From HTS to Phase I: the Institute for Therapeutics Discovery and Development at the University of Minnesota. Dosa PI; Georg GI; Gurvich VJ; Hawkinson JE; Walters MA; Wong HL Comb Chem High Throughput Screen; 2014 Mar; 17(3):231-40. PubMed ID: 24409956 [TBL] [Abstract][Full Text] [Related]
4. The role of HTS in drug discovery at the University of Michigan. Larsen MJ; Larsen SD; Fribley A; Grembecka J; Homan K; Mapp A; Haak A; Nikolovska-Coleska Z; Stuckey JA; Sun D; Sherman DH Comb Chem High Throughput Screen; 2014 Mar; 17(3):210-30. PubMed ID: 24409957 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting caspase-6 activation and catalytic activity for neurodegenerative diseases. Flygare JA; Arkin MR Curr Top Med Chem; 2014; 14(3):319-25. PubMed ID: 24283214 [TBL] [Abstract][Full Text] [Related]
6. The Emory Chemical Biology Discovery Center: leveraging academic innovation to advance novel targets through HTS and beyond. Johns MA; Meyerkord-Belton CL; Du Y; Fu H Comb Chem High Throughput Screen; 2014 Mar; 17(3):290-6. PubMed ID: 24409950 [TBL] [Abstract][Full Text] [Related]
7. Integration of small-molecule discovery in academic biomedical research. Ohlmeyer M; Zhou MM Mt Sinai J Med; 2010; 77(4):350-7. PubMed ID: 20687180 [TBL] [Abstract][Full Text] [Related]
8. UCLA's Molecular Screening Shared Resource: enhancing small molecule discovery with functional genomics and new technology. Damoiseaux R Comb Chem High Throughput Screen; 2014 May; 17(4):356-68. PubMed ID: 24661210 [TBL] [Abstract][Full Text] [Related]
9. Open access high throughput drug discovery in the public domain: a Mount Everest in the making. Roy A; McDonald PR; Sittampalam S; Chaguturu R Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896 [TBL] [Abstract][Full Text] [Related]
10. High throughput screening operations at the University of Kansas. Roy A Comb Chem High Throughput Screen; 2014 May; 17(4):387-93. PubMed ID: 24661207 [TBL] [Abstract][Full Text] [Related]
11. A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research - eighteen million assays and counting. Lackovic K; Lessene G; Falk H; Leuchowius KJ; Baell J; Street I Comb Chem High Throughput Screen; 2014 Mar; 17(3):241-52. PubMed ID: 24409955 [TBL] [Abstract][Full Text] [Related]
12. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery. Liu M; Quinn RJ Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943 [No Abstract] [Full Text] [Related]
14. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits. Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971 [TBL] [Abstract][Full Text] [Related]
15. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575 [TBL] [Abstract][Full Text] [Related]
16. Fragment-based approaches in drug discovery and chemical biology. Scott DE; Coyne AG; Hudson SA; Abell C Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260 [TBL] [Abstract][Full Text] [Related]
17. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective. Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921 [TBL] [Abstract][Full Text] [Related]
18. The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology. McDonald PR; Roy A; Chaguturu R Future Med Chem; 2011 Jul; 3(9):1101-10. PubMed ID: 21806374 [TBL] [Abstract][Full Text] [Related]
19. An Analysis of Different Components of a High-Throughput Screening Library. Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440 [TBL] [Abstract][Full Text] [Related]
20. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease. Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]